Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 224

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

DPP-4 Inhibition by Sitagliptin Improves the Myocardial Response to Dobutamine Stress and Mitigates Stunning in a Pilot Study of Patients With Coronary Artery Disease

Open access
Read, Philip A., Khan, Fakhar Z., Heck, Patrick M., Hoole, Stephen P., Dutka, David P. · 2010 · Circulation: Cardiovascular Imaging

Abstract

Background— Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted postprandially that promotes myocardial glucose uptake. The active amide GLP-1 (7-36) is degraded by the enzyme DPP-4, and drugs that inhibit this enzyme (such as sitagliptin) have been introduced to treat type 2 diabetes. We assessed the hypothesis that increasing the plasma concentration of GLP-1 by DPP-4 inhibition would protect the heart from ischemic left ventricular (LV) dysfunction during dobutamine stress echocardiography in patients with coronary artery disease. Methods and Results— Fourteen patients with coronary artery disease and preserved LV function awaiting revascularization were studied. After either a single dose of 100 mg sitagliptin or placebo, 75 g of glucose was given orally to promote GLP-1 secretion and dobutamine stress echocardiography was conducted with tissue Doppler imaging at rest, peak stress, and 30 minutes. After sitagliptin, plasma GLP-1 (7-36) was increased at peak stress (16.5�10.7 versus 9.7�8.7 pg/mL; P =0.003) and in recovery (12.4�5.5 versus 9.0�5.5 pg/mL; P =0.01), and the LV response to stress was enhanced (ejection fraction, 72.6�7.2 versus 63.9�7.9%, P =0.0001; mitral annular systolic velocity, 12.54�3.18 versus 11.49�2.52 cm/s; P =0.0006). DPP-4 inhibition also improved LV regional function in the 12 paired nonapical segments assessed by peak systolic tissue Doppler (velocity, 10.56�4.49 versus 9.81�4.26 cm/s, P =0.002; strain, −15.9�6.3 versus −14.6�6.6%, P =0.01; strain rate, −2.04�1.04 versus −1.75�0.98 s −1 , P =0.0003). This was predominantly due to a cardioprotective effect on ischemic segments (velocity in ischemic segments, 9.77�4.18 versus 8.74�3.87, P =0.007; velocity in nonischemic segments, 11.51�4.70 versus 11.14�4.38, P =0.14). In recovery, sitagliptin attenuated the postischemic stunning seen after the control study. Conclusions— The augmentation of GLP-1 (7-36) by inhibition of DPP-4 improves global and regional LV performance in response to stress and mitigates postischemic stunning in humans with coronary artery disease. Clinical Trial Registration— URL: http://www.isrctn.org. Unique identifier: ISRCTN78649100.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circimaging.109.899377

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 224

Metadata

Authors
Read, P. A., Khan, F. Z., Heck, P. M., Hoole, S. P., & Dutka, D. P.
Venue
Circulation: Cardiovascular Imaging
Published
2010-03
Volume
3
Issue
2
Pages
195-201
ISSN
  • 1941-9651 (ISSN-L)
  • 1942-0080
OpenAlex
W2043804599
Cited by
224
References
6
FWCI
16.76
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: DPP-4 Inhibition by Sitagliptin Improves the Myocardial Response to Dobutamine Stress and Mitigates Stunning in a Pilot Study of Patients With Coronary Artery Disease. https://app.cochat.ai/papers/10.1161/circimaging.109.899377
The paper
Read, P. A., Khan, F. Z., Heck, P. M., Hoole, S. P., & Dutka, D. P. (2010). DPP-4 Inhibition by Sitagliptin Improves the Myocardial Response to Dobutamine Stress and Mitigates Stunning in a Pilot Study of Patients With Coronary Artery Disease. Circulation: Cardiovascular Imaging. https://doi.org/10.1161/circimaging.109.899377

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.